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Abstract
Extracellular matrix deposition is required for repair after injury, but if left unresolved can result
in fibrosis. Fibrosis is an excess deposition of extracellular matrix proteins following injury or
aging that leads to eventual organ dysfunction. One surgical model that we have used to study
mechanisms of fibrosis is the salivary gland ductal ligation model. During the process
of ligation, a clip is placed on the main ducts of the submandibular (SMG) and sublingual gland
(SLG) which leads from the salivary glands to the mouth. This causes the gland to atrophy, or
waste away, resulting in decreased acinar cell differentiation and death. In the salivary gland, the
acinar cells are cells that line an acinus, which is a small sac-like cavity in the gland into which
saliva is secreted. We can detect loss of acinar cells by immunostaining to detect epithelial cell
proteins like aquaporin 5 (AQP5) which is a water channel protein or conavalin A (ConA).
EpCam-FITC can be used to stain for epithelial cells and Ki67 is a cell proliferation marker that
allows us to observe what cells are proliferating. The longer the clip is held in place during
ligation, the more fibrotic the stroma becomes and the smaller and less productive the salivary
gland will become. The ductal ligation can also serve as a model for recovery from injury
following the removal of the clip, or deligation. Based on previous research in which saliva
production was measured following deligation, acinar cells can fully recover. AQP5 has also
been observed in deligated samples, suggesting that the acinar cells do regenerate during
deligation. It is unknown how quickly after injury the gland begins to recover, and if the
dissipation of the fibrotic response precedes restoration of function. We hypothesize that
following deligation, ECM levels will decrease, prior to the restoration of acinar marker protein
expression. To address this, we will be performing immunofluorescent and histological staining,
IHC, on ligated and deligated tissue cryosections. In this study we will be using C57 mice with a
deligation point or mock surgery point of 3 days. First, we will determine if and when acinar cell
markers, such as AQP5 and ConA return following deligation. Second, we will be examining the
endothelia cells following deligation via IHC staining with CD31 and EpCam-FITC. Lastly, we
will be observing what cell types are proliferating with the marker Ki67. This study will provide
information on the timing of salivary gland recovery from traumatic injury, which may provide
insights into possible regenerative therapies. Depending on the results of this study, we can
modify our ligation/deligation timeline to be potentially shorter than 3 days, or longer than 7
days.
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Chapter 1: Introduction
There are three pairs of major salivary glands in mammals: the submandibular (SMG),
the sublingual (SLG), and the parotid. All three types of glands are similar in structure, in that
the branched ductal system opens up into the oral cavity with saliva being produced by the acini,
which are the secretory endpieces (Holmberg & Hoffman, 2014). These acinar cells are in the
epithelial compartment of the salivary glands. The epithelial compartment also includes ductal
cells and myoepithelial cells. The ductal cells transport and modify the saliva, and the
myoepithelial cells aid in the secretion of saliva from the acinus. The epithelial compartment is
surrounded by the stromal compartment. The stromal compartment includes neurons,
extracellular matrix, endothelial cells, and immune cells. In a healthy mammal, these cells aid in
the creation and production of saliva.
Saliva is important for speech, chewing, and digesting food. The presence of saliva also
protects the mouth from oral infections and cavities. Without the production of saliva, eating dry
foods can become dangerous, because our mouths would be more prone to infection and, if
severe, loss of saliva can even cause loss of taste. Salivary gland hypofunction causes a decrease
in normal gland function, decreasing saliva flow. Hyposalivation can be caused by disease
treatments like irradiation therapy for head and neck cancer and chemical factors like certain
medications. Hyposalivation can also induce gastrointestinal (GI) complications such as pain,
due to the dryness of the pharynx and esophagus, and nausea (Tincani et al., 2013).
One disease that can cause hyposalivation is Sjogren’s syndrome (SS). SS is an
autoimmune inflammatory disorder that mainly impacts the salivary glands and other related
glands. SS presents itself as the combination of both xerophthalmia (dry eyes) and xerostomia
(dry mouth). Xeropthalmia can give rise to many optical issues, such as ulcers and infections and
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xerostomia can give rise to difficulty swallowing, and dental issues. This type of autoimmune
disorder typically requires a predisposed genetic background, but the exact etiology is unknown.
Certain autoantibodies are present in the majority of SS cases, and they are rheumatoid factor
(RF), anti-nuclear antibodies (ANA), but there has not been enough research to conclude if these
can be markers for the development of SS. This disease can present by itself, which is called
primary Sjogren’s syndrome (pSS), or it can present alongside other connective tissue diseases
like rheumatoid arthritis (RA) or lupus, which is known as secondary SS. In the category of
autoimmune rhematic diseases, SS is the second most common disease, and it mostly impacts
women. Past studies have indicated that certain infections may have a protective role against the
development of SS, but the particular way in which infections play a role in the development of
SS is unknown. One main finding is that patients with low vitamin D levels have more adverse
reactions when diagnosed with SS. This outcome can aid researchers in determining if vitamin D
levels play a role in disease development and how they can be used in disease treatment. In
addition to the various symptoms seen in SS patients, another very frequent symptom can be
fatigue. The type of fatigue that is seen in SS patients is physical and somatic rather than a
mental fatigue (Tincani et al., 2013). This disorder is mainly managed by rheumatologists;
however, they work in conjunction with other specialists like ophthalmologists and oral medicine
specialists.
In addition to the more common symptoms above, physicians also have to pay attention
to their patients’ vasculature. In the vascular system, the microvasculature is typically affected in
autoimmune and connective tissue disorders. One way to non-invasively assess the
microvasculature is through nailfold capillaroscopy. One main characteristic that is found in
several autoimmune disorders is a scleroderma pattern (Tektonidou et al., 1999). Scleroderma is
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caused by an over production of collagen in the skin, and it causes a tightening and hardening of
the skin and other connective tissues. One way that scleroderma can reveal itself is through
Raynaud’s phenomena (RP), and in approximately 30% of SS patients have this phenomenon.
Capillaries were examined in multiple SS patients; some had RP and others did not. In the SS
patients that did not have RP, their capillary density was not significantly changed, and in SS
with RP, their capillary density was significantly lower than the control group (Tektonidou et al.,
1999). Demirci et al. (2016), conducted a study in which they examined the vasculature of
female patients with primary SS. One way to observe atrial stiffness is via the blood pressure, a
patient with stiff arteries will have a higher-than-normal systolic blood pressure and a lower
diastolic. Since SS shares many of the same serologic features with rheumatoid arthritis and
lupus, which are both illnesses that include the presence of stiffened arteries. Demirci et al.
(2016), conducted this study because in previous studies it has been noted that in SS there is
increased endothelial dysfunction and atherosclerosis, or narrowing of the arteries; however,
there was not any mention of arterial stiffness. They were able to conclude that in a subset of SS
patients, there is increased arterial stiffness compared to control populations. Atherosclerosis has
also been suggested to be mediated from immune processes due to patients with autoimmune
diseases having increased rate of narrowing vessels. In patients with SS, chronic inflammation
can be one of the main reasons for the increased amounts of atrial stiffness. Both of these studies
strongly suggest that in a subset of SS patients who have reduced micro vessel density, abnormal
vessels, and increased amount of atherosclerosis, endothelial cell dysfunction could be
contributing to salivary gland hyposalivation.
Although there are several common characteristics which can be used to diagnose SS
patients, until 2016 there was not a validated set of criteria across the globe for individuals with
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SS. In 2016, a paper was released with the intent to create a validated set of classification criteria
for diagnosing SS that would be recognized by the American College of Rheumatology (ACR)
and also by the European League against Rheumatism (EULAR). Prior to this study different
organizations had different methods for testing their suspected SS patients the ACR would only
focus on objective tests whereas other organizations would use other symptoms like dry eyes.
This study concluded that in addition to the past requirements to obtain a SS diagnosis, oral
and/or ocular symptoms, patients must also have one of the following symptoms: having antiSSA autoantibodies, an ocular staining score greater than or equal to 5, a Schirmer score of
greater than or equal to 5, and an unstimulated whole saliva flow rate (UWS) of less than or
equal to 1. These 5 different criteria are all summed and weighted together, and if the patient has
a total score of greater than or equal to 4, they meet the criteria to be diagnosed with SS
(Shiboski et al., 2016). In order to ensure the correct weighting of these various components to
SS, there has to be specific ways in which to measure each symptom. For dry eyes, it is
categorized as a complex syndrome that impacts the tear film. Damage to this impacts the
amount of tear production, which causes extreme discomfort and even damage to the eye. The
type of dry eye as seen in SS patients is categorized as aqueous-deficient dry eye, due to lack of
tear production (Tincani et al., 2013). The traditional way to diagnosis SS has been via biopsy of
the salivary glands. Even though these give accurate results, this is an invasive and potentially
dangerous procedure (Niemla et al., 2004). However, only a select few physicians will harvest
the salivary gland and therefore collect the saliva of a potentially ill patient. The saliva can tell a
researcher a lot about what medical condition a person has, or what their physiological state is,
so testing the quality and quantity of saliva is important is detecting diseases like SS (Iorgulescu,
2009).
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In addition to all of the biological and molecular factor that can influence the appearance
of SS, hyposalivation does have other causes. Hyposalivation can also be caused by certain
medications. In a 2017 study conducted by Tan et al., the risk of hyposalivation, as a side effect
of certain drugs, was researched. This study reviewed articles from 1990 up until 2016 that
included any data on dry mouth, salivary gland function, medication use, and the elderly
population. Typically, older adults, aged 60 years or older, tend to take more medications than
the average adult. 40% of the elderly that live in normal communities and approximately 75% of
those who are living in a facility take five or more medications. The mixture of all of these
treatments and the presence of co-morbidities in older adults can increase their risk of adverse
side effects to medications. The most common of these adverse effects is hyposalivation.
Xerostomia is the subjective feeling of dry mouth, but it does not necessarily mean that the
glands are not producing enough saliva. In past studies it has been proven that increased
medication usage leads to and causes hyposalivation, but the severity has not been studied. The
exact mechanisms in which medications can lead to hyposalivation varies, but the main causes
are dehydration, an imbalance in electrolytes, and vasoconstriction in the glands themselves. The
main classes of drugs that can induce dry mouth in individuals are antidepressants,
antipsychotics, antihistamines, sedatives, medicines to regulate high blood pressure
(antihypertensives), medications that inhibit the actin of acetylcholine (anticholinergics), and
cancer therapeutics.
Another type of disease that is known to induce hyposalivation is cancer, specifically
head and neck cancers. Head and neck cancers can involve the salivary glands, and treatment for
head and neck cancers can itself cause salivary hypofunction. Head and neck cancer is
categorized by a board range of tumors that can form anywhere from the upper digestive tract,

5

sinuses, salivary glands, or thyroid glands. In the past two decades the number of smokers has
been on a decline, and in direct correlation from this, the cancer incidence rates have also
declined. Also, in the past two decades racial disparities in cancer treatment and outcomes have
begun to decline. (Siegel et al., 2017). In 2017, there were 49,670 new cases of oral cavity and
pharynx cancers across both sexes. Men have a higher incidence and mortality rate of oral cavity
and pharynx cancers than women. For patients that have head and neck cancer, their treatment
plan is often multidisciplinary. Traditionally, surgery is done first and then followed by
radiotherapy. Unfortunately, the radiation treatment lowers a patient’s quality of life due to its
complications. Depending on the specific location of the tumor, the corresponding treatment
changes, this is because certain locations are inoperable, so radiation is the only option. Some of
the main complications of radiation can be inflammation of the mucosal membranes, which can
cause sore throat and mouth. Some other implication can be the damage to the “sweet tasting”
taste buds, skin irritation, hair loss and loss of sweat and sebaceous gland function. However,
one of the main causes to a lesser quality of life can be the extracting of teeth prior to radiation
therapy. Teeth are extracted if they are deemed non-viable for the long term. Another
complication is edema of the larynx which can cause hoarseness and airway obstruction. All of
these complications happen fairly early on in treatment; however, there are many long-term
effects as well. Xerostomia, dental caries, bone necrosis and several other serious side effects can
stay with these patients for years after treatment (Yeh, 2010). During radiation treatment for
head and neck cancer, there tends to be an increase in fibrotic tissue in the salivary glands.
Fibrosis in the salivary glands can cause the issue of hyposalivation in patients. The fibrotic
tissue impacts the gland function, thus increasing the adverse side effects from the radiation
therapy.
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Current treatments for hyposalivation are only palliative, so the discovery of new
regenerative therapies is needed. According to Wu in 2015, there are different classes of
treatments, the first one aims to increase saliva flow using medication. Muscarinic agonists such
as, pilocarpine, cevimeline, and bethanechol, can be prescribed to stimulate an increase in salvia
production. However, the salvia produced via this route does not contain the proteins that
naturally produced salvia contains. So, although these agonists can increase salvia flow, it is
unknown if they aid in halting the dental issues. This type of treatment is typically given in pill
form and can noticeably begin working in less than an hour. However, after three to four hours,
the pills’ effects wear off, and another needs to be taken. These muscarinic agonists, typically
have some adverse side effects such as sweating, decreased depth perception, diarrhea, and
increased urination. In addition to these side effects, this treatment can become costly, depending
on the specific drug used. There are, however, non-pharmacologic methods to increasing salvia
production. Sugar free gum and hard candies can be used because they are masticatory/gustatory
stimuli. This means that they appear to aid in the stimulation of saliva, however, they only add in
the production of saliva while the object is in the patient’s mouth. Meaning that once you finish a
piece of sugar free gum, you would need to begin chewing another piece, or your saliva flow will
decrease. The third way to increase saliva flow is to use wetting agents, such as salvia
substitutes. One type of wetting agent is the line of Biotene products, which can come in gel or
spray form. Water is most commonly used; some patients will even add oil to their water. In the
case of both wetting agents, they are not long lasting, and there is still not enough information to
state how effective the treatment is (Wu, 2015). In addition to approved treatments, newer
experimental treatments involving stem cells are being tested. Xu et al. (2012), released an
article testing mesenchymal stem cells (MSCs) in those with SS and how MSCs can be used as
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treatment. MSCs are multipotent stem cells, with the ability to differentiate into a variety of cells.
In patients with SS, the MSCs in the bone marrow were defective and unable function normally.
It was determined via experiments on mice and human trials, that MSC treatment can suppress
the autoimmunity seen in SS and restore salivary gland function. Although this is not FDA
approved, this treatment has also been shown to be effective in the treatment of type 1 diabetes
and lupus.
To further examine hyposalivation and SS, the salivary glands have to be examined on a
cellular level. Endothelial cells (ECs) are cells that are found lining the blood vessels and as seen
in previous studies, have been deemed a requirement for the epithelial patterning of the salivary
gland created during the process of vasculogenesis (Kwon et al., 2017). Forming new blood
vessels via angiogenesis is critical for the upkeep and regulation of the organ systems in the
body. ECs are also important in the growth of many tissues through the secretion of paracrine
acting factors, including growth factors, cytokines, chemokines, and ECM components called
angiocrine factors. Past research has determined that these angiocrine factors are derived from
activated ECs. Activated ECs are important in relaying the injury-induced angiocrine factors to
the tissue specific stem cells to push along the process of regeneration. Past regeneration studies
have focused on the liver. The regeneration of the liver has well defined set points and is able to
fully restore the liver back to its original mass prior to resection surgery. In order to determine
how the angiocrine factors relate to regeneration, a surgical resection of 70% of the liver’s mass
was performed. One to four days after this resection, is known as the initial angiogenesisindependent inductive phase. During this phase the non-proliferating liver ECs begin to stimulate
hepatocyte growth factor (HGF). The next time frame is four to twelve days following surgery.
During this phase, the liver ECs stimulate the blood vessels to begin proliferating. During this
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study it was also determined that ECs, derived from the bone marrow that co-express CD31 and
are able to produce HGF, can be placed into the liver to aid in a faster regeneration. In regard to
phase two of liver regeneration, this is when the blood vessels begin to proliferate, and growth
factors begin to rise to their basal levels. Liver ECs are also able to stimulate recovery through
the process of fibrosis. When the bile-duct is ligated, certain receptors can be either repressed or
upregulated with leads to the fibrosis of the liver tissue. This data confirms that liver ECs control
regeneration and homeostasis because they are able to guide other cells and receptors in the
organ when injury or disruption in homeostasis occurs. In addition to the liver, pancreatic studies
have been done with the purpose of trying to resolve the disease of diabetes, lung studies
observing restoration of lung epithelium and cardiac repair have been studied (Rafii et al., 2016).
In addition to maintaining homeostasis, angiocrine factors have been shown to aid the organ
repair from injury. ECs are able to induce organogenesis before angiogenesis and with
collaboration of trophogens, or a substance that impacts the growth of an organ. This study once
again used a 70% resection surgery of the liver in order to observe regeneration. Once the
surgery is performed, the ECs are able to stimulate growth factors with through the release of
trophogens. This allows for the liver to begin regenerating. Angiocrine factors have been shown
to be tissue specific (Ding et al., 2010) and to change in response to different types of injury
(Rafii, 2016). No previous studies have looked into angiocrine factor production in the salivary
gland or the impact of ECs on salivary gland regeneration.
To study mechanisms through which glands can recover from injury, the salivary gland
ductal ligation model has been developed (Woods et al., 2015). During the process of ligation, a
clip is placed on the main ducts of the submandibular (SMG) and sublingual gland (SLG) which
leads from the salivary glands to the mouth. The main excretory duct of the SMG is the
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Wharton’s duct and the main excretory duct of the SLG is the Bartholin’s duct. These two
excretory ducts meet and connect at the sublingual caruncula (Holmber & Hoffman, 2014). In
Cotroneo et al., 2008 they describe the ligation model. First the mice are dosed with anesthesia
(ketamine and xylazine) and through a small incision in the bottom of the mouth the excretory
ducts were clipped with a metal clip. The incision was then sutured. Then two weeks later the
mice were placed under anesthesia again and the clip was removed. Depending on the condition
the glands were removed immediately or after another few days. This surgery protocol was
previously done in other studies and has been shown to cause injury to the glands. During
ligation, extracellular matrix deposition (ECM) increases, causing a reversible fibrosis injury that
affects gland function. Fibrosis is an excess deposition of extracellular matrix that occurs
following injury, which can be detected by Masson’s trichrome stain. With fibrosis, the acinar
cells begin to atrophy as acinar cell loss occurs. The longer the clip is held in the place during
ligation, the smaller and less productive the salivary gland will become. Previous research
conducted by Cotroneo et al in 2008 observed that following ligation, the salivary glands
weighed 50% less than the control glands (unoperated) and for the glands that were deligated 3
days following ligation, the glands began to increase in weight. It was also observed that in the
ligated glands, hematoxylin, and eosin (H & E) staining suggests that the majority of the acini
have disappeared and, through alcian blue/ periodic acid schiff (AB/PAS) staining, the majority
of secretory granules were also gone. After three days, through H&E staining, the acini began to
recover in the SMG and SLG glands, mainly around the edges of the gland. Through the
AB/PAS staining, the glycoprotein content in the acini cells began to return as well; the water
channel protein, aquaporin 5 (AQP5), expression began to increase again in areas where there
were acini. Ki67, a cellular proliferation marker, was not present in the ligated glands, but once
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deligated Ki67 positive nuclei were present suggesting that cells are beginning to proliferate
again. Most previous studies are done in mice, however in 2021 Lutitje et al., examined human
SMG glands, after radiation therapy (RT). They discovered that following that RT treatment, the
SMG had a near complete loss of acinar cells in that acinar cell that expressed functional
secretory markers did remain present in the glands. The ligation model mimics a similar fibrotic
response as to what occurs following radiation surgery phenotypes seen in humans are also seen
in mice with this model.
Deligation is the removal of the clip placed on the duct. Based off previous research,
following deligation, acinar cells can fully recover (Cotroneo, 2008). This data is based off saliva
samples, as saliva production is an indicator of functional acinar cells. During deligation, the
level of functional acini in the salivary gland will begin to increase and the amount of cell
inflammation and fibrosis decreases. Previous work demonstrated that the amount of trichrome
staining decreases after deligation.
The main overall goal of our research is to determine how fibrosis contributes to or
hinders salivary glands regeneration following trauma, since this information can be useful in
developing therapeutics for treatments of diseases like SS where salivary hypofunction occurs.
We want to examine two main questions in my research; the first is what is the timing of the
decrease in ECM and the increase in acinar cells following deligation? Second, we ask what is
the timing of endothelial cell proliferation following deligation? As endothelial cells contribute
to regenerative responses through production of angiocrine factors, which occurs prior to their
proliferation, understanding when their proliferation occurs during gland recovery is critical, I
hypothesize that once the vasculature clip is removed, the increased presence of pro-regenerative
angiocrine factors will aid in the regeneration of salivary glands. In our study, we will be able to
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identify when endothelial cells are recovering and when acinar cells are recovering following
removal of the clip. I will use immunofluorescence staining on mice that have been ligated
compared to mice that have gone through deligation to observe how the levels of each cell type
change using CD31 as an endothelial maker, and EpCam-FITC as an epithelial cell marker. Ding
et al. (2010), found that at in the first three days following injury, liver cells are actively dividing
to replace cells following a liver resection. After this initial division of cells, the endothelial cells
begin to divide in order to provide nutrients to the growing tissue. We want to examine these
timepoints, 3 day and 7 days post injury and observe if this trend also occurs in salivary glands.
This will allow us to determine when the switch between salivary gland cells proliferation and
endothelial cells proliferation occurs.
The work in this paper was performed in collaboration with the following graduate
students in Dr. Melinda Larsen’s laboratory: Amber Altrieth and Kevin O’Keefe. Kevin O’keefe
performed ductal ligation surgeries and processed tissue samples. Amber Altrieth performed
surgeries, processed the resulting tissue samples, and saliva collection. She also supervised the
immunostaining and image quantification that I performed. I assisted Amber with the surgeries
and saliva collections.
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Chapter 2: Materials and Methods
2.1 Mouse Strains and Husbandry
All animal husbandry and procedures were performed in accordance with protocols
approved by the University at Albany, SUNY IACUC committee and housed in 12-hour
light/dark cycle with access to water and dry food. C57BL/6J mice were ordered from the
Jackson Laboratory (Jackson Laboratory #000664) and were given a unique identifier prior to
surgery.
2.2 Ductal Ligation and Deligation Surgery
For the experiments in chapter 3, 12-week-old C57BL/6J female mice were weighed, earpunched and given ketamine/xylazine, an anesthetic, to sedate them before the surgery.
Anesthesia consisted of injecting the mice intraperitoneally (IP) with a solution of 100mg/kg of
Ketamine and 20mg/kg of Xylazine at a dose of 0.1mL/10g of body weight stock solution. Once
the mice were sedated, they were injected subcutaneously with a pain medication composed of
100 µL of 0.015 mg/mL buprenorphine stock solution and secured on the surgery station. Nair
was used to remove the hair from the mouse’s neck, and a combination of betadine and ethanol
was used repeated three times to sterilize the skin for surgery. A surgical drape was then placed
over the mouse, and after a toe pinch to ensure the sedation of the mouse, surgery began.
Scissors were used to make an incision on the neck of the mice, just offset from the midline, and
a combination of forceps and scissors were used to find the salivary glands. Once the glands
were located, the clear duct of the SMG and SLG was clipped with a vasculature clip. Once the
ducts were clipped, the mouse was sutured and placed in a clean cage on top of a warming pad
until recovery from anesthesia. This clip remained on for 14 days. After 14 days mice were either
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harvested or were sedated again, and the vasculature clip was removed for 3 days, or 7 days prior
to harvest. For the mock surgery mice, the ducts were located but no clip was put into place.

Figure 1
Ductal Ligation Surgery Model

Note: Figure 1A, is a cartoon depicting the mouse salivary gland ductal ligation injury model. It allows us to
induce a reversible fibrosis injury to study the mechanisms through which salivary glands can reverse fibrosis.
During ligation in surgeries that were performed by Amber Altrieth, a metal clip is placed on the ducts of the
left submandibular (SMG) and sublingual gland (SLG) which causes the gland to fibrosis (shown by increased
ECM) and gland atrophy with loss of differentiation of the acinar cells that make saliva. In a negative control
mock surgery, an incision is made, and Amber will locate the salivary gland and the corresponding ducts;
however, there is no clip placed. Figure 1B, is an image taken from a ductal ligation surgery, in which the duct
is hooked around the instrument. Figure 1C, is an image of the metal clip placed on the ducts.

2.3 Saliva Collection
A rolled-up cotton pad was placed inside a 0.6mL centrifuge tube with a hole in the
bottom that is inside a 1.75mL centrifuge tube. These tubes were all pre-weighed and labeled
prior to the experiment. Selected mice were weighed and administered 100mg/kg of Ketamine
and 20mg/kg of Xylazine at a dose of 0.1mL/10g of body weight stock solution. After a wait
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time of 3 minutes, we administered a paw pinch to ensure the mice were sedated. The mice were
then restrained on a clean surface using a 50mL conical tube with a hole cut at the bottom. A
heating pad was placed on the surface and the tube was tilted 60 degrees. Pilocarpine
(0.375mg/kg from a 3.75mg/mL stock solution) was given via an IP injection. After waiting 3
minutes, or when the saliva began to flow, whichever came first, a rolled-up cotton pad was
placed in the mouth of each mouse. The saliva was collected into this pad. The cotton pad stayed
in the mouth of each mouse for 15 minutes. The cotton pad was then removed and placed into
the pre-weighed tubes. The tubes were then re-weighed to quantify the total weight of saliva
collected. Centrifuging the tubes allowed for the saliva to be collected into the 1.75 mL
microcentrifuge tube and measured via a pipette. 0.25mL of sterile saline was then administered
subcutaneously (SC) to prevent dehydration and the mice were kept warm until they were able to
ambulate. Once the mice were fully awake, they were placed back in their cages.
2.4 Tissue processing and Cryosectioning
Once glands were removed from the mice, they were placed in 4% paraformaldehyde
(PFA) diluted in 1xPhosphate buffered saline (PBS) for two hours at a temperature of 4 degrees
Celsius. The glands were then washed three times in a 1x PBS solution before being placed into
various sucrose solutions, 5%, 10%, and 15% each for one hour at 4 degrees Celsius. After these
three steps, the glands were placed in a 30% sucrose overnight at 4 degrees Celsius. The next
day, an equal volume of optimal cutting temperature (OCT) tissue freezing medium was added to
the glands, creating a 50% OCT 15% sucrose solution, where the glands were kept overnight at 4
degrees Celsius. The next day, the glands were frozen indirectly over liquid nitrogen. After five
minutes, the samples were moved into the -80 degrees Celsius freezer before being sliced on the
cryostat.
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2.5 Masson’s Trichrome Staining
After taking the desired slides out of the freezer, we waited for them to defrost before
they were placed in Bouin’s Fixative for 20 minutes under the hood. Once the 20 minutes passed,
the slides were rinsed under cold deionized (DI) water for 5 minutes until the yellow color from
the Bouin’s was removed from the tissues. Next, the slides were stained for 5 minutes in
Wiegert’s Iron Hematoxylin for 5 seconds, and then promptly rinsed under cold DI water for 2
minutes. After this rinse, the slides were stained for 15 seconds in Biebrich Scarlett- acid Fuchsin
Solution and then rinsed under cold DI water until the water running off the slides was clear. The
slides were then placed on the bench and 400 µL of phosphotungstic/phosphomolybdic acid was
pipetted directly onto the tissues. The slides sat for 10 minutes, and the acid was discarded via a
kimwipe. Next, the slides were stained in Aniline Blue for 30 seconds and rinsed 3 times for 30
seconds each in cold DI water. Then, the slides were placed on the bench again and 500 µL of
Acetic Acid was pipetted onto the tissue sections for one minute. The Acetic Acid was discarded
in a DI water rinse. The slides were then placed in 95% ethanol, 100% ethanol, and xylene for 2
minutes each. The final step of this protocol was mounting the slides with 55 µL of Permount.
2.6 Immunofluorescence Staining
After taking the prepared slides of a C57BL/6J mouse salivary gland, prepared by Amber
Altrieth, from a -80˚C freezer, they were placed in 4% paraformaldehyde (PFA) for 18 minutes.
Once the 18 minutes was completed, the slides were washed two times for three minutes each in
a 1xPhosphate Buffered Saline (PBS) solution. Following the washes, the slides were placed into
0.5% tx-100 (triton-x 100) solution for 18 minutes, and then washed two more times in 1xPBS.
The slides were then dried with a Kim wipe, and the tissue samples were encircled using a
hydrophobic pen. The wax from the pen dried, and we added blocking solution (3% Bovine
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Serum Albumin (BSA), 0.5% tween-20 solution in 1xPBS) to the samples and let them sit in a
pipette box partially filled with 1XPBS to make a humidified chamber for one hour. Once the
hour was up, the primary antibody solution was added.
For the slides stained in chapter 3 experiment 1, of the C57BL/6J mice, the primary
antibody (Ab) solution was 600 µL total and contained 3µL of rat CD31 (1:200 dilution), 1.5 µL
of rabbit AQP5 (1:400 dilution) and 595.5 µL of 3% BSA. This primary solution was pipetted
onto the slides, and then left to sit overnight in a 4˚C refrigerator in a humidified chamber. After
sitting overnight, we then washed the slides four times in 1xPBS solution for 3 minutes each.
The slides where then placed in 1xPBS and let to sit in the fridge for another 24 hours. For the
next steps, the slides were kept covered and out of direct contact with light. The next day, the
secondary solution was then added. The secondary solution contained 1.2µL of ∝
rabbit Cy2 to detect AQP5, 1.2µL of ∝ rat no mouse Cy5 to detect CD31, 6.0 µL of ConA
lectin and 591.6 µL of 3% BSA 0.5% tx-100. The secondary solution was pipetted onto the
slides in volumes of approximately 150µL and let to sit for one hour, covered from the light.
After one hour, the slides were washed in 1xPBS two times for three minutes. Then the slides
were placed in a 4′,6-diamidino-2-phenylindole (DAPI) solution (1 µg/mL) to label nuclei for 10
minutes followed by two more washes in 1xPBS for three minutes. The slides were then dried
carefully with a Kim wipe and mounted with glycerol-based mounting media (GE). Then the
slides were imaged on an IX-71 Olympus microscope.
For the slides stained in chapter 3 experiment 2, of the C57BL/6J mice, the antibody
solutions were made via the dilution factors indicated in Table 1. This primary solution
containing rabbit Ki67 and rat CD31 was pipetted onto the slides, 125 µL per slide, and then left
to sit overnight in a 4˚C refrigerator in a humidified chamber. After sitting overnight, we then
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washed the slides four times in 1xPBS solution for 5 minutes each. For the next steps, the slides
were kept covered and out of direct contact with light. The secondary solution, containing ∝
rabbit Cy5 to stain for Ki67 and ∝ rat no mouse Cy3 to stain for ECs was pipetted onto the
slides,125 µL per slide, and left to sit for 1 hour. The slides were then washed two times in
1xPBS solution for 5 minutes each. The slides were stored in the final 1xPBS wash and let to sit
in at 4C for another 24 hours with parafilm around the lid. Then the direct conjugate containing
EpCam-FITC solution was pipetted onto the slides, 125 µL per slide and left for 1 hour. After an
hour, the slides were washed two times in 1xPBS solution for 3 minutes each. Then the slides
were placed in a 4′,6-diamidino-2-phenylindole (DAPI) solution (1 µg/mL) to label nuclei for 10
minutes followed by two more washes in 1xPBS for three minutes. The slides were then dried
carefully with a Kim wipe and mounted with glycerol-based mounting media (GE). Then the
slides were imaged on a Zeiss CellObserver microscope.

Table 1
Immunohistochemistry Antibody Information

Primaries

Secondaries

Antibody

Company

Rb mAb to Ki67
Rat anti mouse Cd31
anti-rat no mouseCy3

abcam
BD pharmingen
Jackson
ImunoResearch
Jackson
ImunoResearch
Invitrogen by Thermo
Fisher Scientific

anti-rabbit Cy5
Direct
Conjugate

EpCAM-FITC
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Cat Number

Lot Number

Dilution
Factor
1:100
1:200

ab16667
553370

GR196539-2
7257819

712-166-153

139421

1:500

711-606-152

125599

1:500

11-579182

2028653

1:400

2.7 Trichrome Image Quantification
The trichrome images were captured on a Lecia scope under 5x magnification. Once all
of the images were acquired, Adobe Photoshop version 12 was used to stitch together each gland
in order to create a whole image. In Photoshop, the automate photo-merge option was selected,
and then all of the images for one tissue section were selected. The program then stitched
together all of the images by observing the overlap between images. Once a whole tissue section
was stitched together the image was saved as a tagged image file format (TIF) file.
All stitched trichrome images were quantified using FIJI image software. For the
trichrome images the Fiji editor was opened, and the desired image was opened onto Fiji. The
color threshold was then adjusted to capture the blue ECM stain: the Hue was set to 127-168, the
saturation was set to 50-255 and the brightness was set to 30-255. All slides imaged on the same
day, had the same settings in order to allow for accurate quantification. For outliers, the hue was
adjusted differentially to determine if we could accurately measure trichrome area and is
indicated as such. Once this threshold level was set, and the area of trichrome was selected, a
mask was created. The mask shows only the area of highlighted trichome in white, against a
black screen. The measure function was then used to measure the amount of trichrome on the
mask. Then, the freehand select tool was used to draw an outline around the original tissue
image. A new region of interest (ROI) was created and then the manager function was used to
measure the total amount of gland area in the image. All of the quantifications were compiled in
excel.
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2.8 IHC Image Quantification
All of the chapter 3, experiment 1 IHC slides were imaged on an Olympus IX-71
microscope with a Peltier-cooled CCD camera (Q imaging, RET 4000DC-F-M-12) using a
PLAN S-APO 20X, 0.75 NA objective, and all of the chapter 3 experiment 2 IHC slides were
imaged on Zeiss Z1 Cell Observer widefield with an Axio712 mono camera using a “PlanNeofluar” 20X/0.50 Ph2 M27 objective. The images collected from both scopes were opened
into the Fiji editor software and the background was subtracted. Once these adjustments were
made, the threshold was adjusted and verified using the create selection tool. A mask was then
created and analyzed using the set measurement tool. The measurement allows for the area
selected for in the threshold to be measured. For each day that slides were imaged, the threshold
was set to the same level for each channel. To determine the total tissue area, the Ep-Cam-FITC
channel was used, with no background subtraction, and a threshold was picked so that the entire
tissue section was selected. This threshold was used for all of the sections imaged on one day,
and each day had its own threshold. Once all channels for one tissue section were adjusted and
imaged, the four channels, DAPI, EpCam-FITC, CD31 and Ki67 were merged together to create
a composite image. All channels were then normalized to DAPI or the total tissue area by
dividing the channel area by DAPI or total tissue area.
2.9 Statistical Analysis
All tabulation of quantification was performed in Microsoft Excel. Sections with low
tissue quality due to poor fixation or tissue loss were excluded from quantification. For studies
with only two conditions, an unpaired two-tailed t-test was performed using GraphPad Prism
version 9.1.2 for Windows, GraphPad Software, San Diego, California USA,
www.graphpad.com. For studies with more than two conditions, an Ordinary one-way ANOVA
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with Tukey multiple comparisons analysis was performed using GraphPad Prism. Analysis
containing statistically significant results are indicated by stars over the corresponding bars and
the p values are listed in the figure legends. Analyses with no statistical significance (p < 0.05)
are left unmarked.
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Chapter 3: When do Endothelial Cells Contribute to Recovery from
Salivary Gland Fibrotic Injury?
3.1 Introduction
Endothelial cells (ECs) are cells that are found lining the blood vessels and as seen in
previous studies, have been deemed a requirement for the epithelial patterning of the salivary
gland created during the process of vasculogenesis (Kwon et al., 2017). ECs are also important
in the growth of many tissues through the secretion of paracrine acting factors, including growth
factors, cytokines, chemokines, and ECM components called angiocrine factors (Rafii et al.,
2016). Angiocrine factors are found within the ECs and have been shown to aid the organ repair
from injury. ECs are important during regeneration of many organs and have been shown to
change in response to injury. Angiocrine factors have been shown to be tissue specific (Ding et
al., 2010) and to change in response to different types of injury (Rafii, 2016). No previous
studies have looked into angiocrine factor production in the salivary gland or the impact of ECs
on salivary gland regeneration.
To study mechanisms through which glands can recover from injury, the salivary gland
ductal ligation model has been developed (Woods et al., 2015). During the process of ligation, a
clip is placed on the main ducts of the submandibular (SMG) and sublingual gland (SLG) which
leads from the salivary glands to the mouth. The main excretory duct of the SMG is Wharton’s
duct, and the main excretory duct of the SLG is the Bartholin’s duct. These two excretory ducts
meet and connect at the sublingual caruncula (Holmber & Hoffman, 2014). During ligation,
extracellular matrix deposition (ECM) increases. Excess ECM deposition can result in fibrosis,
which can be detected by Masson’s trichrome stain. Ligation causes a reversible fibrosis injury
that affects gland function. With fibrosis, the gland begins to atrophy or waste away, and acinar
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cell loss occurs. Acinar cells are defined as any cell that lines an acinus, which is a small sac-like
cavity in a gland surrounded by secretory cells, and these cells have been known to decrease
after ligation. The longer the clip is held in the place during ligation, the smaller and less
productive the salivary gland will become.
Deligation is the removal of the clip placed on the duct. Based off previous research,
following deligation, acinar cells can fully recover following deligation (Cotroneo, 2008). This
data is based off saliva samples, as saliva can only be produced if acinar cells are functional.
During deligation, the level of functional acini in the salivary gland will begin to increase and the
amount of cell inflammation and fibrosis decreases. Previous work demonstrated that the amount
of trichrome staining decreases after deligation. However, these studies have not looked at the
endothelial cells and when they begin proliferating during the repair process.
The main purpose of our research is to determine how the salivary glands can regenerate
following trauma, and how this can be useful in developing therapeutics for treatments of
diseases like SS. Current treatments for hyposalivation are only palliative, and so the discovery
of new regenerative therapies is needed. We want to examine two main topics throughout this
research; the first component that we would like to determine is the timing of the decrease in
ECM relative to the increase in acinar cells following deligation. We also want to determine how
endothelial cells may contribute to recovery following deligation. I would hypothesize that once
the vasculature clip is removed, the increased presence of pro-regenerative angiocrine factors
should aid in the regeneration of salivary glands. In our study, we will be able to determine to
what extent the level of endothelial cells increase by quantifying the number of CD31-positive
cells present in the glands and when they are proliferative by counting the number of Ki67+,
CD31+ cells in salivary glands that have been ligated compared to gland that have gone through
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delegation. We will identify the timepoint when the endothelial cells start to proliferate as we
will identify angiocrine factors from ECs just prior to cell proliferation in future studies.
3.2 Methods
All methods used in this chapter are explained in chapter 2 of this paper. The methods
used for this set of experiment were mouse breeding and husbandry, ductal ligation and
deligation surgery, Masson’s trichrome staining, immunofluorescence staining, and statistical
analysis.
3.3 Results
Experiment 1:
Ductal ligation surgeries were performed on the left glands of 12-week-old female
C57BL/6 mice which were prepared for cryosectioning and IHC. Some of the glands were
harvested without removing the clips (ligated control) and on some the clips were removed and
the glands were allowed to regenerate (delegated). These glands were compared to time zero
mice in which the SMGs were harvested at the time of surgery and mock surgery. Slides from
C57BL/6 mice were stained and imaged. Four of the slides were used as a control, meaning that
the gland was harvested from a 3-day mock surgery where the ducts corresponding to the SMG
gland were not ligated. The meaning of this control was getting a baseline of where each cell
level is at prior to injury and eliminating any effects of the surgical manipulation itself. The other
5 slides were of 3-day deligated tissue, which were obtained from glands three days after
removal of the clip. For the T0 mouse there were 6 slides used and the 14-day ligated tissue had
a sample size of 8.
When completing the immunofluorescence staining, we stained for acinar cells via the
staining of glycoproteins and glycolipids, concanavalin A (ConA), and AQP5, endothelial cells
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via CD31, and DAPI, which labels the cell nuclei. AQP5 was detected with a Cy2 conjugated
secondary antibody and is important to this study as it stains for the water channel proteins, and
therefore indicates where the acinar cells are. ConA was detected with a Cy3 secondary antibody
and stains for glycoproteins and glycolipids present within the saliva, and therefore also indicates
where the acinar cells are located and if they are producing glycoproteins and glycolipids. CD31
was detected with a Cy5 conjugated secondary antibody and is a cell surface receptor on
endothelial cells within blood vessels; and DAPI stains for cell nuclei. These stains allow for us
to determine if the cells in the salivary gland are beginning to regenerate or if there are still in an
injured, fibrotic state. Immunofluorescence staining was used to stain certain cell markers and
the FIJI software system was used to quantify the data. We used a lectin, conavalinA (ConA),
which comes from the jack bean and binds to glycoproteins, which was conjugated to a
fluorophore and exposed it to tissue sections obtained from deligated and mock surgery control
glands to examine levels of glycoproteins in glands 3 days after deligation. Figure 2A shows a
composite image from the apical side of a 14-day ligated surgery mouse identified as L1. Figure
2B shows a composite image from the distal region of the gland of a deligated C57BL/6 mouse,
identified as R1L2. The gray color is representative of DAPI, which stained the nucleus of each
cell. The magenta color is representative of ConA and stains the glycoproteins and glycolipids
present the in saliva. The deligated slide has tissue that was ligated for 14 days and deligated for
3 days prior to harvest.
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Figure 2
ConA detection of glycoproteins in deligated salivary glands

100um

Note: We used a lectin, conavalin (ConA), which was conjugated to a fluorophore, and exposed it to tissue sections
obtained from deligated and mock surgery control glands to examine levels of glycoproteins in glands 3 days after
deligation. ConA Lectin is magenta and DAPI (gray), stains for the cell nuclei. Figure 2A is the 14-day ligated
gland tissue and Figure 2B is the 3 day deligated tissue.

As a complementary method to examine the acinar cell recovery, we performed IHC to
detect the water channel protein, aquaporin 5. We exposed the deligated and control tissues to an
antibody to detect AQP5 (green) followed by a secondary antibody conjugated to a fluorophore.
the gray stain is DAPI, and that stains for the cell nuclei. In Figure 3, we stained for AQP5 to
demark acinar cells within the SMG gland. Figure 3A, is composite image from the apical side
of a deligated C57 mouse with the identity of R1L1. This slide was ligated for a period of 14
days and then deligated for 3. Figure 3B is a composite image from the apical side of a 3-day
mock C57 mouse identified as R1. After we finished imaging our IHC images using FIJI, we
were able to quantify the areas of each stain relative to the stain for DAPI. Figure 3C illustrates
the quantifications for the AQP5 stain normalized to DAPI. The deligated tissue has 0.8-fold less
AQP5 positive area when compared to the mock control but more than the delegated glands. The
T-test that we ran yielded a value of 0.45, which means the difference is non-significant.
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Figure 3
AQP levels in deligated salivary glands.
3 day deligated

C

B

DAPI AQP5

A

3-day MOCK

100um

Note: Figure 3A shows 3 day deligated gland tissue and Figure 3B shows 3-day mock gland tissue. IHC was
performed to detect AQP5 (green) and DAPI (gray). Figure 3C the area positive for AQP5 was quantified relative
to the area positive for the nuclear stain, DAPI. We expressed the AQP5/DAPI area levels as a fold change relative
to the mock tissue. The error bars correspond to S.E.M. n=4 for the mock and n=5 for the deligated tissue.

In addition to staining for acinar cells using ConA and AQP5, saliva measurements are
another way to monitor salivary gland recovery. We wanted to determine if stimulated saliva
measurements could be used to determine successful ligation upstream of deligation surgery.
Saliva was collected at 1, 2, 4, and 6 weeks to determine how injury impacts the acinar cells.
Weeks 1, 2, and 4 provide us with the baseline data and week 6 was one week after surgery. If
the acinar cells are injured, less saliva should be produced. We induced saliva production in 15
C57 female mice using pilocarpine prior to injury and post-surgery to observe what the effect of
ligation is on the production and secretion of saliva. In Figure 4A, saliva weights for weeks 1, 2
and 4 were averaged together to create the before surgery saliva weight. Week 6 saliva weight
was measured 1 week after ligation surgery. All of the saliva weights were then normalized to
mouse weight (NMW). After the mice were harvested, the glands were weighted and a cut off
was created to define which glands had successful ligation. The cutoff range was between 0.019
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and 0.044g, and any left gland that fell within this range was considered a successful ligation.
Only the left gland was examined, as we only ligated one gland. The mice that appeared to have
a successful ligation were, R1, R2, R2L1, R2L2 and R3, with left gland weights of 0.035g,
0.033g, 0.029g, 0.031g, and 0.027g respectively. These glands were marked with an asterisk in
Figure 4A. There was no trend between successful ligation and lower saliva production, and this
can be seen in Figure 4B.
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Figure 4
Quantification of Saliva production before and after ligation surgery

Note: After following the saliva collection protocol, saliva was collected during weeks 1, 2, and 4 leading up to
ligation surgery, and one week post ligation surgery, week 6. In Figure 4A all of the weights were then normalized
to mouse weight. The first four mice were used as controls, and not ligated. The mice identifications with asterisks
in the name, are considered to have successful ligation surgeries. Figure 4B, shows the correlation between
successful ligation, which was determined by gland weight and saliva weight.
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After comparing multiple methods for assessing salivary gland function, we next focused
on the endothelial cells, which may promote salivary gland regeneration after deligation. To
examine endothelial cells in the blood vessels, we preformed IHC to detect CD31, a cell surface
marker that expressed by endothelial cells. We compared the gland before injury (T0), after 14
days ligation, after 14 days ligation with 3 days deligation, relative to a 3-day day delegation
mock surgery. In Figure 5, we used CD31, as shown in red, to stain for the endothelial cells in
the SMG. CD31 is a cell surface marker that expressed by endothelial cells. The grey stain
shown in these images is DAPI, or the nuclear stain. Figure 5A is the gland at T0, this tissue was
not exposed to any injury and allows us to determine the level of ECs in a healthy, normal,
salivary gland. Figure 5B is the SMG directly following the 14-day ligation. This tissue
indicates the levels of ECs in a fibrotic, injured gland. Figure 5C is the 3-day mock tissue, and
this mouse was not ligated at all, however it did undergo two rounds of exploratory surgery, in
which the salivary gland and its corresponding ducts were located but not ligated or deligated.
This tissue was from the apical side of the R1L1 C57 female mouse. Figure 5D is the 3-day
deligated SMG tissue, and this image allows us to get a glimpse into what the gland is beginning
to do following the removal of the source of injury. This tissue was from the apical side of the
R1 C57 female mouse.
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Figure 5
Endothelial cells in injured and control salivary glands
100um

A

B

C
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Note: To examine endothelial cells in the blood vessels, we preformed IHC, to detect CD31(red) and DAPI (gray)
for cell nuclei. We compared the gland before injury at T0 (Figure 5A), after 14 days ligation (Figure 5B). We next
compared the 3-day mock tissue (Figure 5C) and 3-deligated tissue (Figure 5D).

We compared the gland before injury (T0) and after 14 days ligation and saw that the
endothelial cells present increased by more than 2-fold by quantifying the area positive for CD31
relative to DAPI. We next compared the deligated tissue and found that it has 1.5-fold more
CD31 stain than the mock. The trend shown is that the ECs are increasing with ligation and
remaining present after deligation. Figure 6 illustrates the quantifications for the value of
positive CD31 stain relative to DAPI. The trend that can be seen is that the ECs are increasing
following ligation and remaining relatively high 3-days after deligation. We ran a one-way
ANOVA test which yielded the differences between each of our values as non-significant, expect
for the difference between the 3-day mock and 14-day ligated samples; suggesting that the ECs
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are increasing with injury, but the endothelial cell area does not expand significantly after
deligation.
Figure 6
Quantification of CD31 in ligated and deligated salivary glands.

Note: After preforming IHC on 3-day mock and 3 day deligated tissue, we were able to quantify the area positive for
CD31 relative to the area positive for the nuclear stain, DAPI. We expressed the CD31 area levels as a fold change
relative to the mock tissue. The 14- day ligated tissue was harvested before the gland was deligated, and the T0
tissue was harvested prior to any induction of injury. The error bars correspond to S.E.M.
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Experiment 2:
To compare the extent of the fibrotic response following delegation, we performed a
ligation surgery for 2 weeks followed by a delegation for either three days or seven days and
compared the extent of ECM deposition by trichrome staining. 41 slides, containing tissue from
41 C57 female mice were selected for this trichrome experiment. There were 15 slides, with a
sample size of 30 salivary gland tissues for the 3 day deligated condition. There were 7 slides,
with a sample size of 20 salivary gland tissues for the 7 day deligated. There were 5 slides, with
a sample size of 5 for the 14 ligated condition. For the 3-day Mock condition, there were 9
slides, with a sample size of 18 salivary gland tissue section and lastly, for the 7-day Mock
condition there were 5 slides, with a sample size of 15 tissue samples. In figure 7A one
representative tissue section from each experimental condition is shown. These tissue sections
were all stained using Mason’s trichrome. Trichrome staining was quantified using ImageJ.
Below each stitched trichrome image in this figure, there is a mask highlighting the area of the
tissue that was identified as ECM. In quantifications, the masks are used to ensure that we are
measuring the correct amount of ECM, with little to no background. Figure 7B is a graph
depicting the average trichrome, or ECM, area across all of the conditions. The average
trichrome area is a percent, pertaining to the amount of ECM divided by the total tissue area. The
3-day mock condition has an average trichome area of 5.6 percent compared to the total tissue
area. The 7-day mock condition has an average trichome area of 5.9 percent of the total tissue
area. The 14-day ligated sample has an average trichrome area of 18.1 percent of the total tissue
area. The 3 day deligated sample has an average trichome area of 9.5 percent of the total tissue
area and the 7 day deligated sample has an average trichome area of 12.1 percent of total tissue
area. The differences between the two mock conditions were not significant and the differences
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between the two deligated condition is not significant. But the difference between the each of the
mock conditions and each of the deligated conditions is significant when compared to the 14-day
ligated sample. In Figure 7C there is an example of a representative mask, which is picking up
primarily ECM staining. This tissue is the 3 day deligated sample as seen in Figure 7A, and as
shown, the mask is correctly highlighting the amount of ECM present in the cell. Figure 7D
indicates a trichrome sample that did not allow for proper ECM definition. The trichrome stain
itself appears to be overly blue, which can be further confirmed by the mask that captures most
of the tissue. Since the tissue color itself is too close to the ECM color after trichrome stained,
the software is unable to distinguish the area of tissue positive for ECM when compared to the
total tissue area. This is why the mask appears to be a mask of the whole tissue. This image was
deemed to be an outlier and was not included in the quantification.
Of the 41 slides stained for ECM with trichrome in Figure 7A-C, there were tissue
sections from surgeries performed by two different researchers, Amber Altrieth, and Dr. Kevin
O’Keefe. To determine if the surgical technique by the two researchers was equivalent, we
compared gland size and trichrome staining. After the glands were harvested, the weights were
compared and found to be similar (data not shown). Trichrome staining was also compared. In
Figure 7E the three day deligated and three-day mock tissue sections were compared from these
two researchers in order to determine if the two surgeon’s samples could be combined with one
another. Although the mock surgery results were the most variable, there was no significant
difference between the trichrome staining results from the surgeries performed by the two
researchers, indicating that all of the surgical data could be compared in the same experiment.
Due to not having any 7-day data to compare Dr. Kevin O’Keefe vs Amber Altrieth, data, we
choose to stay with solely Amber’s surgery glands in subsequent figures.
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Figure 7
Trichrome quantifications of C57 mice
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Note: In Figure 7A there is a stitched Trichrome image of each condition with its corresponding mask under it. We
measure the amount of Trichrome from an image. When the staining is done correctly, the trichrome will end up
becoming a dark blue color, whereas the rest of the tissue will remain a pink color. This allows for us to use NIH
Imaging software to select all of the blue colored trichrome, which can be seen in the mask. Figure 7B is a graph of
the Trichrome quantifications for each condition. Each condition is on the x-axis and the average trichrome area is
on the y-axis. A one-way ANOVA test was used to obtain the significance. Figure 7C is a depiction of a correct
mask. The tissue was correctly stained, and the mask correctly indicates the trichrome area. Figure 7D shows what
happens when something goes wrong with the staining. As seen in the colored image, it is difficult to distinguish the
trichrome from the remaining tissue. As much as we have an issue with distinguishing the tissue, the programing
software has the same issue. The software cannot tell the difference between the trichome and other tissue, and
therefore selects it all, which can be seen in the mask. Tissue sections that showed a pattern similar to this were
excluded from our calculations, as they are inaccurate and over-select the trichrome area. Figure 7E shows the
comparison between two different researchers’ 3 day deligated and MOCK surgeries.

When conducting the immunohistochemistry staining for this experiment, we stained for
DAPI, EpCam-FITC, CD31, and Ki67. DAPI stains for the cell nucleus and allows us to
visualize each cell. CD31 is in the Cy5 stain and is a cell surface receptor on endothelial cells
blood vessels and stains for them. EpCam-FITC is in the Cy2 stain and is an is a cell surface
receptor on epithelial cells; and Ki67 is a cell proliferation marker in the Cy3 stain. These stains
allow for us to determine at what stage the salivary gland cells are beginning to proliferate.
Immunofluorescence staining was used to stain certain cell markers and the FIJI software system
was used to analyze the data. Over the course of 5 days, 20 slides from C57 mice were stained
and imaged. 3 of the slides were used as a control, meaning that the gland was harvested form a
3-day mock surgery, and the ducts corresponding to the SMG gland were not ligated. The
meaning of this control was getting a baseline of where each cell level is at prior to injury. The
other 17 slides were of 3-day deligated tissue, 7 day deligated, and 14-day ligated tissue. In
Figure 8A the IHC images from each condition are shown. Within each condition there is an
image of DAPI with EpCam-FITC, DAPI with CD31, DAPI with Ki67 and a composite of all
stains. Figure 8B is a graph of the area of EpCam-FITC positive stain over total tissue area for
each tissue. The EpCam-FITC area average normalized to total tissue area are 0.261, 0.220,
0.230, 0.200 for the 3-day mock, 14 days ligated, 3 day deligated and 7 day deligated
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respectively In Figure 8C there is a graph indicating the CD31 positive area over the total tissue
area. The CD31 area average normalized to total tissue area are 0.029, 0.090, 0.043, 0.096, for
the 3-day mock, 14-day ligated, 3 day deligated and 7 day deligated respectively. In Figure 8D
there is a graph of the Ki67 positive area over the total tissue area. The Ki67 average area
normalized to total tissue area are 0.005, 0.015, 0.049, and 0.012 for 3-day mock, 14-day ligated,
3 day deligated and 7 day deligated respectively. In Figure 8E the quantitation of DAPI area
over total tissue area is shown for each condition. The DAPI areas normalized to total tissue area
are 0.257, 0.436, 0.300,0.355 for the 3-day mock, 14 days ligated, 3 day deligated and 7 day
deligated respectively A one-way ANOVA test was used with these all of these quantifications in
order to obtain the significance between conditions. Although we do not have any significant
changes in our data, we can observe that EpCam-FITC levels remain constant across all
conditions, and that CD31 levels are increasing when the tissue is injured, 14-day ligation,
decrease at the 3-day deligation and increase at 7 day-deligation; both of which has been shown
in previous research. The Ki67 positive stain is relatively low at the 3-day mock and 14 ligation
timepoints, which is what previous literature has suggested, and peaks at the 3-day deligation
timepoint. Lastly, the DAPI stain stays constant across all conditions, which is what is expected.
These findings suggest that we should examine between 3- and 7-days post deligation.
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Figure 8
Immunohistochemistry of C57 mice between various conditions
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Note: In Figure 8A IHC images are shown for each of the following conditions: 3-day MOCK, 14 days ligated, 3
day deligated and 7 day deligated. For each condition there is an image of DAPI with EpCam-FITC, DAPI with
CD31, DAPI with Ki67 and a composite with all of the stains. This allows us to visualize how the stains are
fluctuating between each condition. Figure 8B is a graph of the EpCam-FITC positive area was normalized to the
total tissue area. In Figure 8C the area positive CD31 was quantified and normalized to the total tissue area. Figure
8D is a graph of the Ki67 positive area normalized to the total tissue area. In Figure 8E the DAPI positive area
normalized to the total tissue area was quantified for each condition. The statistics for figures 8B-E were ran with a
one-way ANOVA test

3.4 Discussion
Experiment 1:
Throughout IHC staining and saliva collections we were able to state what happens to the
SMG gland when injured. We used the ductal ligation-deligation model to induce a reversible
injury in the mice, and after 14 days of ligation, we removed the clip. The days following
deligation, we were able to observe how, or if, the SMG gland was beginning to recover. We
focused specifically on acinar and endothelial cells in our IHC. Our results indicate that at 3days, the acinar cells are not expanding, and the endothelial cell levels are still high. This
suggests that the salivary gland is not yet beginning to recover, as there is still inflammation
present (high EC positive tissue).
Our first method in examining the SMG was IHC. We did a total of three different stains,
two for acinar cell markers and one for ECs. In Figures 2, 3 and 5, the immunofluorescence
staining protocol was used to stain certain cell markers. This was done on C57BL/6 mice to
observe how the cells within the SMG gland respond to injury. In Figure 2, the ConA stain is
shown. As seen by the images, the 3-day deligated tissue (Figure 2B) has the most ConA
positive area, compared to the 14-day ligated (Figure 2A) conditions. We were not able to
quantify this stain, but the amount of ConA appears to increase following deligation.
The second acinar cell marker that we examined via IHC was AQP5. In Figure 3, there is
more AQP5 staining in the deligated tissue (Figure 3A), when compared to the mock tissue
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(Figure 3B), indicating that the acinar cells have not fully recovered following ligation. In
Figure 3C we were able to quantify the areas positive for AQP5. Figure 3C depicts the area
positive for AQP5 relative to DAPI and as shown, there is more positive area of AQP5 in the
mock tissue when compared to the deligated, which indicates that the acinar cells have not fully
recovered 3 days after deligation. The difference between the deligated and mock tissue areas
positive for AQP5 were not significant according to our T-Test. This could be do a low sample
size of 4 mock and 5 deligated glands and could also be due to high variability, as we have one
sample in each condition that have very high levels; so, a larger sample size could allow us to see
if our values are significant given the level of variability. If the SMG was beginning to recover,
we would begin to see the acinar cell levels return to control/mock levels; however, that is not
what we observed meaning that at 3 days. The acinar cells in the gland are not recovering at 3
days. However, previous research done by Cotroneo in 2008 on rats concludes that 3-days after
deligation the morphological traits, such as acinar cells, begin to return in the SMG. Although
our findings do not match these findings and that could be due to difference in recovery times
between the two types of animals, our findings were not significant. Once, we increase our nvalue, for these experiments, we will be able to more accurately state how our findings relate to
past research.
To examine how injury impacts the SMG in a broader sense, we performed a saliva
collection on mice pre- and post-ligation. In Figure 4A, the saliva weight collection was
graphed. As shown by the graph, it seems that some of the saliva production decreased following
ligation; however, when we harvested the glands there was little to no change in weight,
suggesting that ligation was not successful. From this data, we can conclude that pilocarpineinduced saliva measurements are not a reliable way to determine successful ligation. We are only
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affecting one gland with the surgery and stimulated saliva tends to stimulate primarily the parotid
gland (which is unaffected in our surgery), so this could be a major reason as to why this
technique was ineffective. It is possible to canulate the submandibular gland to collect just saliva
from one SMG at a time, which could be tested in future experiments (Kuriki et al., 2011).
Figure 4B is showing the correlation between the glands that were successfully ligated, which
we determined from gland weight, and saliva weight. As can be seen from the figure, there is no
correlation between ligation and saliva production with this methodology.
Due the discovery that the acinar cells have not fully recovered after 3- or 7-days following
ligation, we next observed the ECs since they have a known role in both inflammation, and
regeneration. To examine how injury impacts the SMG, we choose to stain for CD31, which is
an EC marker. In Figure 5, we compared the IHC staining compositions at four different time
points. Figure 5A is the SMG tissue at T0, which means that the gland was harvested prior to
any induction of injury. This image gives us a comparison of what a normal, healthy SMG
gland’s EC level should be. Figure 5B, is SMG tissue 14 days after ligation, which means that
the ducts were never deligated, the glands were just harvested after ligation. This allows to us
observe what the EC levels are like at the peak level of fibrosis. Figure 5C is from the R1, 3-day
mock C57 female mouse, which means that the mouse underwent a mock surgery, and 3 days
later the glands were collected. This allows us to observe what happens to the SMG gland when
the mouse itself is placed under stress and injured. Figure 5D is from the R1L1, 3-day deligated
C57 female mouse. This tissue is what we are focusing on, as this will tell us what the ECs look
like after the removal of the source of injury. In Figure 6, we were able to quantify the areas
positive for CD31. Figure 6 depicts the area positive for CD31 relative to the area for DAPI.
The number of ECs present in the 14-day deligated tissue was 2-fold higher than the T0 tissue
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and the number of ECs present in the 3-day deligated tissue was 1.5-fold higher than the mock
tissue. This trend indicates that the ECs are increasing with ligation and remaining high 3-days
following deligation. We expect for the ECs to be high when they are activated, in times of
injury or inflammation and repair. Due to the EC levels remaining high 3 days following
deligation, the inflammation might still be present. The differences in the areas positive for
CD31 between each time point are not significant, except for the difference between the 3-day
mock and 14-day ligated samples. This insignificance could be due to the limited sample size for
T0, 14-day ligated, 3-day deligated and mock which was 8, 5, 5, and 4 respectively, or due to
high variability between mice. The significance between the 3-day mock and 14-day ligated
samples indicates that the ligation was successful, as the increase in ECs correlates with recovery
from injury.
Experiment 2:
Mason’s trichrome was used to quantify the levels of ECM deposition present in each of
our surgical conditions. In Figure 7A, one composite trichrome image from each condition was
chosen, with its appropriate mask. We can observe that the 3- and 7-day MOCK tissue sections
visually had the least amount of trichrome. This is what we would expect because the glands
themselves were not being injured. The 14-day ligated condition seemed to have the most
trichrome stain, which is also what we would expect because the gland was injured and not given
any time to recover. Lastly, the 3-day 7 day deligated tissue samples were similar in the amount
of trichrome visually present in the images. In order to comment on the amount of trichrome
more accurately in each image, Figure 7B contains a graph of the average trichrome area in each
condition normalized to the total tissue area. Between the 3- and 7-day MOCK conditions, there
was no significant difference in trichrome area. This is what we would expect since the salivary
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glands are not being injured in these two conditions. The 14-day ligated samples had the most
trichrome in the images, and in the quantifications. There is a significant difference between each
of the other conditions and the 14-day ligated condition suggesting that the gland is recovering
and confirms that this is a reversible fibrosis since it is decreasing after deligation. For the last
two conditions, the 3 and 7 day deligated samples, there was no significant difference in
trichrome levels. This is also consistent with the images in Figure 7A. All of these findings are
consistent with previous literature on fibrotic diseases; the amount of ECM will increase when
the tissue is being injured, and as the tissue begins to recover the amount of ECM will begin to
decrease. To better understand how we measured the amount of trichrome present in each tissue
sample, Figure 7C is an accurate representation of an appropriately stained tissue and an
appropriate mask. The mask should highlight the areas of the tissue that are blue (the ECM), and
when we can correctly highlight the ECM-positive area, then we can accurately measure the
correct amount of trichrome in the tissue sample. However, staining does not always work
correctly, sometimes due to age or quality of the fixed tissue. Figure 7D is an example of a
tissue sample, whose staining did not turn out as expected. This stained tissue sample ended up
being overly blue, which is an issue because in the FIJI imaging software we use, it measures the
amount of trichome by the amount of blue stained tissue. If the whole tissue sample is blue, as
this one is, the mask will highlight the total tissue. This yields us an untrue quantification, as the
whole tissue is not solely composed of ECM. We omitted all of the tissue samples, five slides,
that had this issue, as it would have inaccurately represented the percent area covered by ECM
deposition.
Another variable we examined while staining for trichrome was variability in samples
due to different surgeons. For this comparison all of these slides were trichrome stained and
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quantified in order to determine how different the surgeries were between two surgeons, Amber
Altrieth, and Dr. Kevin O’Keefe. If each person performed the surgeries in a similar manner, we
would expect to see no significant difference between the quantifications for the same condition.
This is what we saw when we compared the data. There is no significant difference between
Kevin and Amber’s 3-day deligated samples, and there was no significant difference between
their 3-day MOCK tissue samples either. However, after comparison of techniques, Amber and
Kevin performed their mock surgeries differently and we choose to only use Amber’s slides for
the final trichrome quantifications. In addition, there were no 7-day mock surgery samples of
Kevin’s that we could use for comparison, and only Amber had a significant difference between
her 3-day deligated and 3-day MOCK samples. For these reasons, we used only Amber’s
samples in the subsequent analysis.
We also examined the amount of different cell types of presents using
immunohistochemistry. To determine when the cells in salivary glands are proliferating, we
conducted IHC on 20 slides and performed IHC to detect DAPI, EpCam-FITC, CD31 and Ki67.
In Figure 8A the 3-day MOCK, 14-day ligated, 3-day deligated and 7-day deligated conditions
are shown. Within each condition, a merged image for each stain was shown, in addition to the
final composite image containing all of the stains. The EpCam-FITC appears to stay consistent
across all of the conditions, and the CD31 appears to increase at 14-day ligation, decrease at 3
days of deligation and then increase again. This is consistent with previous literature as in the
Cy2 channel, we can stain for acinar cells and ductal cells. Past findings have indicated that
fibrosis decreases acinar cells but increases ductal cells. Although EpCAM is an epithelial
marker, it is expressed more strongly in ducts more strongly than acini. Interestingly, we
observed that over the course of ligation and deligation, the EpCam-FITC stain remained
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relatively constant. This could be because the number of acinar cells that are lost are canceled
out by the number of ductal cells gained, resulting in a similar area covered by EpCAM. The
CD31 stain, stains the endothelial cells within the tissue, which appears to increase at the 14-day
ligation timepoint, decrease 3 days following deligation and then increase again. This is also
consistent with what we expected because as the tissue becomes more injured and fibrotic, the
amount of blood vessels has to increase in order to supply the fibrotic tissue with blood. The
amount of blood vessels then decreases when the amount of ECM decreases, and the increase
again once the tissue begins to recover. Lastly, the Ki67 stain is at its lowest at the 3-day MOCK
condition and with the next lowest condition being the 14-day ligated. This is what we would
expect when because the tissue is not injured, i.e., the MOCK condition, and when the tissue has
no chance to regenerate, i.e., the 14-day ligated condition, few cells should be proliferating. The
Ki67 appears to increase from the 3 day deligated to the 7 day deligated condition suggesting
that cells in the salivary gland are beginning to proliferate following deligation. Additionally, we
quantified the amount of each stain normalized to the total tissue area. Figure 8B is the
quantifications for the amount of EpCam-FITC positive area, and once again there is no
significant difference across any of the conditions. This is consistent with the image in Figure
8A and with past literature. In Figure 8C, the amount of CD31 positive area was quantified, and
although the levels of CD31 are the highest at the 14-day ligation and 7-day deligation, which is
consistent with the images in Figure 8A, and past literature, the difference is not significant. In
Figure 8D, the amount of Ki67 positive area was measured and although there appear to be a
huge increase in Ki67 in the 3 day deligated condition, the difference between this condition and
the others is not significantly important. The overall trend in Ki67 levels, extremely low at 3-day
MOCK and 14-day ligation, with an increase at 3 days post deligation, is promising for future
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studies. In Figure 8E the amount of DAPI, or cell nuclei, stain was quantified and there was no
significant difference between any condition. This is what we expect to see, as the number of
cells in the tissue sample should not be changing.
This experiment suggests that the salivary gland is beginning to recover from fibrotic
injury starting at 3 days post deligation. As our goal was to determine at what timepoint the ECs
are proliferating, we will need to compare the overlap between the Ki76 proliferation marker and
CD31, the endothelial cell marker to determine when there are proliferating cells. Although most
of our data did not have any significance, our data suggests that 3 days appears to be too early,
and by 7 days the ECs appear to be increasing in area, which may be due to proliferation, which
we can confirm by counting Ki67+ ECs. As our next step is to perform single cell sequencing on
endothelial cells at a timepoint prior to cell proliferation, these data suggest that an intermediate
time pint between 3 and 7 days may be ideal for examining angiocrine factors produced by ECs
and their contributions to salivary gland regeneration.
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Chapter 4: Conclusions and Future Directions
4.1 Conclusions
The study in chapter 3, enables us to examine the ligation/deligation model using mouse
salivary glands. Throughout this study, this model has been beneficial in inducing injury in the
salivary glands and allows us to study on the molecular level how the salivary glands are
transforming when injured.
Chapter 3 suggested the timepoint when the ECs are being to proliferate in the ductal
ligation model, 3 days post deligation. This was determined through IHC staining with the
markers CD31 and Ki67. Ki67 levels allowed us to pinpoint when proliferation is occurring in
the positively stained cells. Through trichrome staining we were able to determine that after 14
days of being ligated the glands had the most ECM, meaning they had the most amount of
fibrotic tissue. Once the glands were deligated, the amount of ECM decreased, showing that the
amount of injured, fibrotic tissue decreased. Although none of our quantifications were
significant, they are promising for more experiments moving forward. All of the data from
experiment 1; need larger sample sizes in order to determine significance and accurately
determine how ConA and AQP5 vary with injury. The data from experiment 2 suggest that 3
days post deligation is a good time point to begin examining the regeneration of the salivary
glands. In future work, we will quantify the co-positivity of Ki67 with the specific cell types with
manual counting.
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4.2 Future Directions
After completing the experiments in chapter 3, there are still many studies we need to do in
order to confirm the time point for when the endothelial cells are proliferating following
deligation. We would like to find better methodologies for evaluating successful ligation, more
specifically experiment with various saliva collection techniques. We will also need to quantify
the amount of CD31 and Ki67 co-positive cells. This will tell us when the endothelial cells
specifically are beginning to proliferate following ligation. In addition to examining CD31 copositivity with Ki67, we will also be examining EpCAM-FITC, AQP5 and DAPI co-positive
cells with Ki67. This will enable us to assess the acinar cell proliferative response to deligation.
Here, we specifically focused on 3-day data, but moving forward we will examine the 7-day
tissue. Previous research conducted by Contorneo discovered that acinar cells were found
starting to recover at about 5 days and were further recovered by day 7 via IHC staining for
AQP5. To examine how much the acinar cells are recovering at these two time points, we will do
more IHC staining and compare the AQP5 levels and glycoprotein levels at both 3 and 7 days.
In the future we also plan to trichrome stain 3 and 7 day deligated tissue with specific stains for
acinar cell markers. This will allow for us to determine the relationship between acinar cell
markers recovery and reduction in fibrosis. We completed IHC and trichrome quantifications in
order to pinpoint when the cells are beginning to proliferate, and in the future, we will use single
cell RNA sequencing to determine what angiocrine factors produced by endothelial cells are
contributing to the regrowth of glands following regeneration. This single cell RNA sequencing
will enable us in the future to study these factors and determine potential new therapeutics for
individuals suffering from SS.
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